Eurofins Scientific has announced the acquisition of assets to establish a fully-equipped, state-of-the-art laboratory campus in Genome Valley, Hyderabad. The acquisition includes a facility capable of supporting large global and Indian pharmaceutical clients as well as small biotech companies in the areas of synthetic organic chemistry, analytical R&D, bioanalytical services (for both large and small molecules), in-vivo pharmacology, safety toxicology and formulation R&D. The state-of-the-art laboratories occupy over 90,000 ft2.
The announcement was made after Minister Mr. KT Rama Rao’s meeting with Eurofins management at the World Economic Forum in Davos. Mr. Jayesh Ranjan IAS, Principal Secretary, Industries and Commerce Department and Mr. Shakthi M Nagappan, Director Lifesciences, Government of Telangana were also present during the meeting.
With this investment through its subsidiary Eurofins Advinus, the Eurofins network now has a significant campus in Hyderabad that complements its existing operations in India with additional capacity in discovery chemistry, analytical chemistry and bioanalytical services. The investment will also allow Eurofins Advinus to extend its service offering to deliver formulation development as well as in-vitro and in-vivo biology capabilities from early 2023.
Hyderabad is regarded as the epicenter of drug discovery and development services in Asia, while Genome Valley is India’s first organized cluster for Life Sciences R&D and Clean Manufacturing activities, with world-class infrastructure facilities in the form of Industrial / Knowledge Parks, Special Economic Zones (SEZs), multi-tenanted dry and wet laboratories and incubation facilities. Genome Valley is home to more than 200 companies with a scientific workforce of about 15,000 professionals, working for industry leaders in global and Indian pharmaceuticals. This investment by Eurofins Advinus further reinforces the position of Hyderabad as a world class location for drug discovery.
Subscribe to our e-Newsletters
Stay up to date with the latest news, articles, and events. Plus, get special
offers from Pharmaceutical Outsourcing – all delivered right to your inbox! Sign up now!